Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years
Table 3
The fate of patients with unsuccessful PEI therapy.
Number
Type of nodule
Age (ys)
Size of the nodule before first PEI (V0), mL
Time elapsed until 2nd therapy (ys)
Size of nodule before 2nd therapy, mL (% of V0)
Type of 2nd therapy
Last visit after the 2nd therapy (ys)
Size of nodule on the last visit (% of V0)
Final result
2.
Nontoxic, cystic
25
24.9
2
69.1
Repeated PEI
6
12.0
Success
5.
Nontoxic, cystic
39
11.9
2
98.3
Repeated PEI
2
81.6
Surgery
7.
Nontoxic, solid
30
10.1
7
78.2
Repeated PEI
2
37.8
Success
8.
Nontoxic, solid1
32
8.9
10
68.5
No therapy
—
10.
Nontoxic, solid
37
21.9
8
70.8
Surgery
—
11.
Toxic
20
13.8
2
46.4
I-131 therapy
—
Although one PEI-series was unsuccessful in Patient 8, she requires no second therapy because her nodule causes no problem.
